Premium
Late‐onset hematological complications post COVID ‐19: An emerging medical problem for the hematologist
Author(s) -
Korompoki Eleni,
Gavriatopoulou Maria,
Fotiou Despina,
NtanasisStathopoulos Ioannis,
Dimopoulos Meletios A.,
Terpos Evangelos
Publication year - 2022
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26384
Subject(s) - medicine , hematologist , covid-19 , coagulopathy , pandemic , disease , intensive care medicine , hematology , immune dysregulation , coronavirus , immunology , immune system , pediatrics , infectious disease (medical specialty) , virology , outbreak
Abstract Coronavirus disease 19 (COVID‐19) is considered a multisystemic disease. Several studies have reported persistent symptoms or late‐onset complications after acute COVID‐19, including post‐COVID‐19 hematological disorders. COVID‐19‐induced coagulopathy, an immunothrombotic state, has been linked to thromboembolic and hemorrhagic events. Late‐onset thrombocytopenia related to immune system dysregulation has also been reported as a rare manifestation post COVID‐19. Close monitoring of laboratory dynamics is considered essential to identify timely abnormal values that need further investigation, providing supportive care whenever indicated. The role of hematologists is essential in terms of the multidisciplinary approach of long COVID‐19. This review summarizes all the available evidence on post‐acute COVID‐19 hematological complications.